Long-term results of the DelIVery for Pulmonary Arterial Hypertension trial.

Mardi Gomberg-Maitland,Robert C Bourge,Shelley M Shapiro,James H Tarver,Dianne L Zwicke,Jeremy P Feldman,Murali M Chakinala,Robert P Frantz,Fernando Torres,Remzi Bag, Jeffrey A Murphy, Amy A Lautenbach,Marty Morris,Leigh Peterson,Aaron B Waxman

PULMONARY CIRCULATION（2019）

引用 13|浏览59

暂无评分

摘要

Delivery of treprostinil with an intravascular delivery system is a safe alternative to an external delivery system, while providing enhanced life experiences. To preserve the risk-benefit ratio, treatment at specialized pulmonary arterial hypertension centers is recommended until training is disseminated at other sites.

查看译文

关键词

internal device,prostacyclin,pulmonary arterial hypertension,treprostinil

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要